-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lp5rgHwJnI5o7uXElv7olNXC5CoRnPv+30Sw/pY19M64sPknWG49I6hQmVWS5Xwr yp7+NneQLcjVggyC7g+hzA== 0001464475-09-000002.txt : 20090522 0001464475-09-000002.hdr.sgml : 20090522 20090520133435 ACCESSION NUMBER: 0001464475-09-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090519 FILED AS OF DATE: 20090520 DATE AS OF CHANGE: 20090520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Medeiros Paul CENTRAL INDEX KEY: 0001464475 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 09841918 MAIL ADDRESS: STREET 1: 4575 SW RESEARCH WAY STREET 2: SUITE 200 CITY: CORVALLIS STATE: OR ZIP: 97333 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVI BIOPHARMA INC CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: STE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 BUSINESS PHONE: 5032270554 MAIL ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: SUITE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2009-05-19 0 0000873303 AVI BIOPHARMA INC AVII 0001464475 Medeiros Paul 4575 SW RESEARCH WAY SUITE 200 CORVALLIS OR 97333 0 1 0 0 SVP/Business Development Incentive Stock Option (Right to Buy) 1.1 2009-05-19 4 A 0 272727 0 A 2010-05-19 2019-05-19 Common Stock 272727 272727 D Non-Qualified Stock Option (Right to Buy) 1.1 2009-05-19 4 A 0 127273 0 A 2010-05-19 2019-05-19 Common Stock 127273 127273 D The Stock Option Grant vest as follows: 1/3 vest one year from date of grant and 1/3 each year thereafter until all shares vest three years from grant date. Paul Medeiros 2009-05-20 -----END PRIVACY-ENHANCED MESSAGE-----